1. Autoantibodies directed against apolipoprotein-A1 as a potential contributor to non-alcoholic fatty liver disease. (August 2021) Authors: Pagano, S.; Alfaiate, D.; Juillard, C.; Frias, M.; Magenta, A.; Martino, F.; Sciacqua, A.; Succurro, E.; Burger, F.; Brandt, K.J.; Andreozzi, F.; Mach, F.; Perticone, M.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High antibody titers against apolipoprotein-A1 in NAFLD: A possible link between fatty liver disease and CVD?. (August 2022) Authors: Pagano, S.; Alfaiate, D.; Juillard, C.; Frias, M.; Magenta, A.; Martino, F.; Sciaqua, A.; Succurro, E.; Burger, F.; Brandt, K.J.; Andreozzi, F.; Mach, F.; Perticone, M.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗